Organon & Co.
OGN
Peringkat dalam Saham
#4356
Organon & Co., a global pharmaceutical enterprise, is dedicated to developing... Organon & Co., a global pharmaceutical enterprise, is dedicated to developing and delivering a wide array of prescription therapies. Its women's health division features reproductive care products, encompassing birth control and fertility treatments, notably Nexplanon/Implanon, an extended-duration contraceptive. The company's biosimilars collection includes three immune-related medications (Brenzys, Renflexis, Hadlima) and two cancer therapies (Ontruzant, Aybintio). Additionally, Organon provides cardiovascular medications, such as cholesterol-reducing drugs (Zetia, Ezetrol, Vytorin, Inegy, Rosuzet, Zocor) and treatments for high blood pressure (Cozaar, Hyzaar). Their respiratory product line addresses asthma symptoms with brands like Singulair, Dulera, Zenhale, and Asmanex, and manages seasonal allergies through Singulair, Nasonex, Clarinex, and Aerius. Furthermore, their offerings extend to dermatological care (Diprosone, Elocon), bone strengthening (Fosamax), and non-narcotic pain relief (Arcoxia, Diprospan, Celestone). The portfolio also comprises Proscar for treating symptomatic benign prostatic hyperplasia and Propecia for combating male pattern hair loss. The company's products are primarily distributed to pharmaceutical wholesalers, retailers, medical facilities, government entities, and various managed healthcare organizations, including health maintenance organizations and pharmacy benefit managers. Organon & Co. was established in 2020 and is headquartered in Jersey City, New Jersey.
Harga Saham
$13.76
Terakhir disinkronkan: 2026-10-20
Kapitalisasi Pasar
$3.61B
Perubahan (1 hari)
0.07%
Perubahan (1 tahun)
52.49%
Negara
US
Perdagangan Organon & Co. (OGN)
Kategori
Healthcare
Jumlah saham beredar untuk Organon & Co. (OGN)
Jumlah saham beredar per June 2026: 262.61M
Menurut laporan keuangan terbaru dan harga saham Organon & Co., jumlah saham beredar saat ini adalah 262.61M. Pada akhir December 2024, perusahaan memiliki 257.05M saham beredar. Jumlah saham beredar biasanya dipengaruhi oleh pemecahan saham dan pembelian kembali saham.
Riwayat saham beredar untuk Organon & Co. (OGN) dari 2017 hingga 2026
Saham beredar pada akhir setiap tahun
| Tahun | Saham Beredar | Mengubah |
|---|---|---|
| 2026 (TTM) | 262.61M | 1.20% |
| 2025 | 259.50M | 0.95% |
| 2024 | 257.05M | 0.71% |
| 2023 | 255.24M | 0.46% |
| 2022 | 254.08M | 0.21% |
| 2021 | 253.55M | 0.01% |
| 2020 | 253.52M | 0.15% |
| 2019 | 253.13M | 0.00% |
| 2018 | 253.13M | 0.00% |
| 2017 | 253.13M | 0.00% |
Saham beredar untuk perusahaan serupa atau pesaing
| Perusahaan | Saham Beredar | Perbedaan | Negara |
|---|---|---|---|
| 892.40M | 239.82% |
US
|
|
| 2.45B | 832.01% |
US
|
|
| 1.77B | 574.38% |
US
|
|
| 0.00 | -100.00% |
US
|
|
| 796.00M | 203.11% |
CH
|
